117 related articles for article (PubMed ID: 11137845)
41. Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.
Cherian P; Hankey GJ; Eikelboom JW; Thom J; Baker RI; McQuillan A; Staton J; Yi Q
Stroke; 2003 Sep; 34(9):2132-7. PubMed ID: 12907813
[TBL] [Abstract][Full Text] [Related]
42. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
[TBL] [Abstract][Full Text] [Related]
43. Helicobacter pylori seropositivity is associated with enhanced platelet activation in patients with intermittent claudication.
Cassar K; Bachoo P; Ford I; McGee M; Greaves M; Brittenden J
J Vasc Surg; 2004 Mar; 39(3):560-4. PubMed ID: 14981449
[TBL] [Abstract][Full Text] [Related]
44. Acquired von Willebrand syndrome in aortic stenosis.
Vincentelli A; Susen S; Le Tourneau T; Six I; Fabre O; Juthier F; Bauters A; Decoene C; Goudemand J; Prat A; Jude B
N Engl J Med; 2003 Jul; 349(4):343-9. PubMed ID: 12878741
[TBL] [Abstract][Full Text] [Related]
45. Stentless Bioprostheses for Aortic Valve Replacement in Octogenarians: The Influence of Coronary Artery Disease.
Ennker J; Zadeh B; Pons-Kuehnemann J; Niemann B; Grieshaber P; Ennker IC; Boening A
Thorac Cardiovasc Surg; 2018 Jun; 66(4):322-327. PubMed ID: 28675910
[TBL] [Abstract][Full Text] [Related]
46. Surgical Enlargement of the Aortic Root Does Not Increase the Operative Risk of Aortic Valve Replacement.
Rocha RV; Manlhiot C; Feindel CM; Yau TM; Mueller B; David TE; Ouzounian M
Circulation; 2018 Apr; 137(15):1585-1594. PubMed ID: 29167226
[TBL] [Abstract][Full Text] [Related]
47. Indices of thrombogenesis, endothelial damage and platelet function following percutaneous peripheral artery angiography and angioplasty for peripheral vascular disease.
Makin AJ; Chung NA; Silverman SH; Moss MS; Lip GY
Pathophysiol Haemost Thromb; 2003; 33(2):102-8. PubMed ID: 14624052
[TBL] [Abstract][Full Text] [Related]
48. Five-year follow up of the ATS mechanical heart valve.
Emery RW; Krogh CC; Jones DJ; Nicoloff DM; Blake DP; Arom KV
J Heart Valve Dis; 2004 Mar; 13(2):231-8. PubMed ID: 15086262
[TBL] [Abstract][Full Text] [Related]
49. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms.
Lip GY; Lowe GD; Metcalfe MJ; Rumley A; Dunn FG
Am J Cardiol; 1995 Sep; 76(7):453-8. PubMed ID: 7653443
[TBL] [Abstract][Full Text] [Related]
50. Management of dilated ascending aorta during aortic valve replacement: valve replacement alone versus aorta wrapping versus aorta replacement.
Lee SH; Kim JB; Kim DH; Jung SH; Choo SJ; Chung CH; Lee JW
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):802-9. PubMed ID: 23856198
[TBL] [Abstract][Full Text] [Related]
51. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome.
Genc H; Dogru T; Tapan S; Tasci I; Bozoglu E; Gok M; Aslan F; Celebi G; Erdem G; Avcu F; Ural AU; Sonmez A
Clin Biochem; 2012 Jan; 45(1-2):92-5. PubMed ID: 22100896
[TBL] [Abstract][Full Text] [Related]
52. Plasma fibrin clot properties affect blood loss after surgical aortic valve replacement for aortic stenosis.
Mazur P; Natorska J; Sobczyk D; Gaweda B; Bartus K; Filip G; Kapelak B; Undas A
Eur J Cardiothorac Surg; 2019 Feb; 55(2):224-231. PubMed ID: 30063794
[TBL] [Abstract][Full Text] [Related]
53. Von Willebrand's disease following aortic valve replacement.
Singh S; Klarich K; Beckman T
J Heart Valve Dis; 2012 May; 21(3):405-6. PubMed ID: 22808848
[No Abstract] [Full Text] [Related]
54. High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men.
Jilma B; Cvitko T; Winter-Fabry A; Petroczi K; Quehenberger P; Blann AD
Thromb Haemost; 2005 Oct; 94(4):797-801. PubMed ID: 16270633
[TBL] [Abstract][Full Text] [Related]
55. Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement, using a St. Jude Medical prosthesis.
Byrne JG; Leacche M
J Heart Valve Dis; 2010 Jul; 19(4):471-2. PubMed ID: 20845895
[No Abstract] [Full Text] [Related]
56. [Von Willebrand factor and soluble P-selectin in patients with non ST-Elevation acute coronary syndrome during treatment with glycoprotein IIb/IIIa antagonist eptifibatide].
Mazaev AA; Naĭmushin IaA; Khaspekova SG; Golubeva NV; Ruda MIa; Mazurov AV
Kardiologiia; 2007; 47(6):4-9. PubMed ID: 18260867
[TBL] [Abstract][Full Text] [Related]
57. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.
Solomon C; Budde U; Schneppenheim S; Czaja E; Hagl C; Schoechl H; von Depka M; Rahe-Meyer N
Br J Anaesth; 2011 Apr; 106(4):494-500. PubMed ID: 21278152
[TBL] [Abstract][Full Text] [Related]
58. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.
Weber A; Noureddine H; Englberger L; Dick F; Gahl B; Aymard T; Czerny M; Tevaearai H; Stalder M; Carrel TP
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1075-83. PubMed ID: 22341653
[TBL] [Abstract][Full Text] [Related]
59. Re-do aortic valve replacement: does a previous homograft influence the operative outcome?
Kumar P; Athanasiou T; Ali A; Nair S; Oz BS; DeSouza A; Moat N; Shore DF; Pepper JR
J Heart Valve Dis; 2004 Nov; 13(6):904-12; discussion 912-3. PubMed ID: 15597580
[TBL] [Abstract][Full Text] [Related]
60. Clinical evaluation of the carbomedics prosthesis: experience at providence health system in Portland.
Minakata K; Wu Y; Zerr KJ; Grunkemeier GL; Handy JR; Ahmad A; Starr A; Furnary AP
J Heart Valve Dis; 2002 Nov; 11(6):844-50. PubMed ID: 12479287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
